(Q61907466)

English

Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor

clinical trial

Statements

SANDMAN (English)
0 references
Randomized, Multi-center, Double-blind, Placebo-controlled, Group-comparison Study to Investigate Safety, Tolerability and Pharmacodynamics of BAY2253651 After Administration of a Single Nasal Dose in 60 Subjects With Obstructive Sleep Apnea and Open Exploratory Evaluation of Safety and Local Tolerability of Repeated Doses in Patients (English)
0 references
0 references
0 references
0 references
0 references
13 August 2018
0 references
31 January 2020
0 references
60
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit